nejm retatrutide phase 2 trial obesity 2023 triple agonist 2023年度回顧】 Notable Articles of Day GLP-1 Receptor Agonists | New

Over a six-month protocol, the cumulative time saved by using a pen versus a syringe adds up to hours

Retrieved from Goacki, J., Matuszek, M., & Matyjaszek-Matuszek, B

This underscores that these medications require long-term, potentially lifelong use to maintain benefitsa consideration with significant cost and adherence implications

2019 Available online: fdc.nal.usda.gov

The nutritionists were always kind and supportive throughout my weight loss journey

35,36 While the subsequent GUIDE-HF trial did not find a difference in cardiovascular outcomes using PA pressure monitoring, a newly published trial based out of Europe, MONITOR-HF, demonstrated findings similar to the earlier CHAMPION trial that PA pressure monitoring to guide HF management reduced HF-related hospitalizations and improved quality of life